160 related articles for article (PubMed ID: 24648378)
21. Model-free tests of equality in binary data under an incomplete block design.
Lui KJ; Zhu L
J Biopharm Stat; 2018; 28(6):1160-1168. PubMed ID: 29452049
[TBL] [Abstract][Full Text] [Related]
22. Block urn design - a new randomization algorithm for sequential trials with two or more treatments and balanced or unbalanced allocation.
Zhao W; Weng Y
Contemp Clin Trials; 2011 Nov; 32(6):953-61. PubMed ID: 21893215
[TBL] [Abstract][Full Text] [Related]
23. Randomization-based interval estimation in randomized clinical trials.
Wang Y; Rosenberger WF
Stat Med; 2020 Sep; 39(21):2843-2854. PubMed ID: 32491198
[TBL] [Abstract][Full Text] [Related]
24. Dynamic randomization and a randomization model for clinical trials data.
Kaiser LD
Stat Med; 2012 Dec; 31(29):3858-73. PubMed ID: 22763807
[TBL] [Abstract][Full Text] [Related]
25. Robustness of response-adaptive randomization.
Ye X; Hu F; Ma W
Biometrics; 2024 Mar; 80(2):. PubMed ID: 38819309
[TBL] [Abstract][Full Text] [Related]
26. Statistical properties of randomization in clinical trials.
Lachin JM
Control Clin Trials; 1988 Dec; 9(4):289-311. PubMed ID: 3060315
[TBL] [Abstract][Full Text] [Related]
27. Generalized linear mixed model for binary outcomes when covariates are subject to measurement errors and detection limits.
Xie X; Xue X; Strickler HD
Stat Med; 2018 Jan; 37(1):119-136. PubMed ID: 28980332
[TBL] [Abstract][Full Text] [Related]
28. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance.
Durán Pacheco G; Hattendorf J; Colford JM; Mäusezahl D; Smith T
Stat Med; 2009 Oct; 28(24):2989-3011. PubMed ID: 19672840
[TBL] [Abstract][Full Text] [Related]
29. Using severity rather than randomization for assignment in clinical trials: Monte Carlo tests and practical illustrations of the Robbins-Zhang method.
Ross DC
J Psychiatr Res; 1995; 29(4):315-32. PubMed ID: 8847658
[TBL] [Abstract][Full Text] [Related]
30. A stepped wedge design for testing an effect of intranasal insulin on cognitive development of children with Phelan-McDermid syndrome: A comparison of different designs.
Van den Heuvel ER; Zwanenburg RJ; Van Ravenswaaij-Arts CM
Stat Methods Med Res; 2017 Apr; 26(2):766-775. PubMed ID: 25411323
[TBL] [Abstract][Full Text] [Related]
31. Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates.
Li Y; Ma W; Qin Y; Hu F
Stat Methods Med Res; 2021 Sep; 30(9):2148-2164. PubMed ID: 33899607
[TBL] [Abstract][Full Text] [Related]
32. Comparisons of minimization and Atkinson's algorithm.
Senn S; Anisimov VV; Fedorov VV
Stat Med; 2010 Mar; 29(7-8):721-30. PubMed ID: 20213718
[TBL] [Abstract][Full Text] [Related]
33. Joint modeling of survival time and longitudinal data with subject-specific changepoints in the covariates.
Tapsoba Jde D; Lee SM; Wang CY
Stat Med; 2011 Feb; 30(3):232-49. PubMed ID: 21213341
[TBL] [Abstract][Full Text] [Related]
34. Causal inference from longitudinal studies with baseline randomization.
Toh S; Hernán MA
Int J Biostat; 2008 Oct; 4(1):Article 22. PubMed ID: 20231914
[TBL] [Abstract][Full Text] [Related]
35. A randomization test wrapper for synthesizing single-case experiments using multilevel models: A Monte Carlo simulation study.
Michiels B; Tanious R; De TK; Onghena P
Behav Res Methods; 2020 Apr; 52(2):654-666. PubMed ID: 31270794
[TBL] [Abstract][Full Text] [Related]
36. Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs.
Piccorelli AV; Fraker SA
J Biopharm Stat; 2018; 28(6):1105-1118. PubMed ID: 29442610
[TBL] [Abstract][Full Text] [Related]
37. The asymptotic maximal procedure for subject randomization in clinical trials.
Zhao W; Berger VW; Yu Z
Stat Methods Med Res; 2018 Jul; 27(7):2142-2153. PubMed ID: 27856960
[TBL] [Abstract][Full Text] [Related]
38. Drop-outs and a random regression model.
Overall JE
J Biopharm Stat; 1997 Jul; 7(3):383-402. PubMed ID: 9252832
[TBL] [Abstract][Full Text] [Related]
39. The gradient function as an exploratory goodness-of-fit assessment of the random-effects distribution in mixed models.
Verbeke G; Molenberghs G
Biostatistics; 2013 Jul; 14(3):477-90. PubMed ID: 23376427
[TBL] [Abstract][Full Text] [Related]
40. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
Fazzari MJ; Kim MY; Heo M
J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
